Does intravenous vitamin C actually work?
Intravenous vitamin C is one of the most-cited claims in the IV-therapy world — and one of the most-misunderstood. The literature is split between strong evidence in specific applications and unsupported marketing claims in others. The difference between them is dose, indication, and bioavailability.
Oral vitamin C absorption saturates around 200 mg per dose. Above that, additional intake is largely excreted. Intravenous administration bypasses the saturation ceiling — a 2000 mg IV dose can reach plasma concentrations 30–70 times higher than the maximum possible from oral intake. Whether that high plasma level translates to clinical effect depends on what you're measuring.
Where the evidence is strong
Collagen synthesis. Vitamin C is a required cofactor for prolyl and lysyl hydroxylases in the collagen pathway. At plasma concentrations achievable only by IV, the supply ceiling is removed and collagen production increases. This is the mechanism behind Beauty Elite protocols and the basis of vitamin C's role in connective-tissue support.
Antioxidant capacity in plasma. At IV doses, vitamin C contributes measurably to total antioxidant capacity and regenerates oxidized vitamin E and glutathione in tissue. This is the mechanism behind the Detox and Recovery protocols.
Immune function. Vitamin C supports neutrophil function and lymphocyte proliferation at plasma levels above those reachable by oral intake. Clinical relevance is well established in deficiency states and supported in supplementation literature.
Where the evidence is weak
Cancer treatment. High-dose IV vitamin C has been studied for decades in oncology with mixed results. The Riordan and Padayatty papers show pharmacological-dose plasma levels reaching cytotoxicity in vitro, but clinical outcomes in trials have been inconsistent. We do not market IV vitamin C as an oncology intervention.
Cold and flu prevention. Despite popular use, the evidence for IV vitamin C reducing common cold incidence in well-nourished adults is weak. The strongest signal is in deficiency or in athletes under heavy training loads — and even there the effect is modest.
The dose threshold
Vitamin C doses below 1000 mg per IV session are not pharmacologically different from a high-end oral protocol. The threshold for pharmacological effect — meaning plasma concentrations unreachable by oral intake — is around 1000–2000 mg by IV. The Beauty Elite protocol uses 1000 mg; Detox uses 2000 mg; clinical oncology protocols range higher.
G6PD screening matters. High-dose IV vitamin C is contraindicated in glucose-6-phosphate dehydrogenase deficiency because of haemolysis risk. INFUZE tests before any Detox session.
Common questions
- Can I just take vitamin C tablets instead?
- For routine supplementation, yes. For pharmacological plasma concentrations — the dose level that affects collagen synthesis or plasma antioxidant capacity — oral intake cannot reach the same range due to absorption saturation.
- Is high-dose IV vitamin C safe for the kidneys?
- In normal kidney function, the doses in our protocols are safe. We screen for kidney function before high-dose Detox sessions. Clients with stage 3+ chronic kidney disease are not appropriate for high-dose protocols.
- How often is safe?
- Beauty Elite at 1000 mg weekly for the 4-week protocol is well tolerated. Detox at 2000 mg quarterly is the standard cadence. We don't run weekly high-dose vitamin C protocols outside specific indications.